
Please try another search
On today’s episode of the Zacks Friday Finish Line, Content Writer Ryan McQueeney and Editor Maddy Johnson take on this week’s biggest stories, including the progress made on the GOP tax bill, North Korea’s missile test, bitcoin’s historic week, and what it all means for the stock market in 2018.
Make sure to subscribe and leave the show a rating on iTunes!
Throughout the week, investors reacted to a number of different headlines. From bitcoin reaching historic milestones, to North Korea testing new weapons and the Republicans making progress on their long-awaited tax bill, Wall Street has had plenty to grapple with.
With tax cuts in the pipeline, a new Fed chair set to be confirmed, heightening geopolitical tensions, and more attention than ever on the cryptocurrency market, there looks to be quite the busy ending to 2017.
We had already seen some of these headlines result in real effects. Bank stocks, led by JPMorgan (NYSE:JPM) and Bank of America (NYSE:BAC) were soaring this week, while tech behemoths, especially Amazon (NASDAQ:AMZN) and Apple (NASDAQ:AAPL) , suffered a major selloff on Wednesday.
Maddy and Ryan discussed these effects and highlighted the key factors that could influence these stocks as we approach 2018.
Make sure to tune into the show to hear more!
As a reminder, if you feel that we missed something, or if you want us to cover a different story, shoot us an email at podcast@zacks.com. Make sure to check out all of our other audio content at zacks.com/podcasts, and remember to subscribe and leave us a rating on iTunes.
As always, thanks for listening to this episode of the Zacks Friday Finish Line, and check back for even more news from the investment and financial world!
Want more stock market analysis from this author? Make sure to follow @Ryan_McQueeney on Twitter!
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>
The fortune of Nvidia (NASDAQ:NVDA) is closely tied to Big Tech hyperscalers. Although the AI/GPU designer didn’t name its largest clients in the latest 10-K filing on Wednesday,...
Home improvement retailers Lowe’s (NYSE:LOW) and Home Depot (NYSE:HD) turned a corner, and their Q4 2024 earnings reports confirmed it. The corner is a return to comparable store...
One of our old flames, a former Contrarian Income Portfolio holding, has pulled back sharply in recent weeks. Time to buy the dip in this 4.3% dividend? Let’s discuss. Kinder...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.